Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • ODM-207 – First-in-human Phase 1 study of BET inhibitor for solid tumour patients

Blocking autophagy to prevent old age organ decline? Find out

Microbiology & Biotechnology Research Recruitment at PGIMER

ODM-207 – First-in-human Phase 1 study of BET inhibitor for solid tumour patients
  • BiotechToday
  • World

ODM-207 – First-in-human Phase 1 study of BET inhibitor for solid tumour patients

bioxone October 1, 2020October 1, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA

BET (Bromodomain and extra terminal domain) proteins are described to be epigenetic and anti-cancer drug targets. This was the first-in-human study that judged the pharmacokinetics and prior activity of ODM-20, the inhibitor of BET in patients having solid tumours. 

The main objective was to determine the tolerability, dose-limiting toxicities (DLT), and also the maximum tolerated dose (MTD) of the patients subjected to solid tumours. The second objective is to exemplify the pharmacokinetics of the inhibitor, mainly to assess the effects of food bioavailability and also to cause the preliminary verification of the anti-tumour activity. 

The study design consisted of two parts:

 1) The escalation of dose to the patients having advanced solid tumours 

2)  Rating of the effect of food on the bioavailability 

For the patients having an advanced solid tumour, a single dose was given with the accelerated titration procedure, in the very first division, which involved the comparison of the pharmacokinetic parameters in the first division of the patients to check whether it reached the targeted range or otherwise. If not, the dose was given in a 3+3 schedule. The food effect involved the single accelerated dose after the washout period ODM-207 after breakfast. 

About thirty-five patients were treated with ODM-207, some common AE’s were observed, nevertheless, ODM-207 shows great increasing exposure in the dose, and was safe at the doses to 2mg/kg but had a tapered therapeutic window. 

The registration number for the clinical trial being NCT03035591.

Also read: Blocking autophagy to prevent old age organ decline? Find out

Citation : Malaka Ameratunga , Irene Brana , Petri Bono , Ruth Plummer , John Aspegren , Timo Korjamo , Amir Snapir  , Sophie Postel-Vinay and JohannS de Bono . 

Site: https://www.nature.com/articles/s41416-020-01077-z

For more updates: https://bioxone.in

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged 3+3 schedule anti-cancer BET bioavailability DLT dose drug escalation MTD ODM-207 parameters pharmacokinetic single cohort tumour

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Microbiology & Biotechnology Research Recruitment at PGIMER

bioxone October 1, 2020

-Shristi Sharma, Team bioXone MSc Microbiology and Life Science Candidates Apply. Research jobs at PGIMER. PGIMER is hiring MSc candidates for SRF Jobs. Interested and eligible candidates can check out all the details:  DEPARTMENT OF MEDICAL MICROBIOLOGY POSTGRADUATE INSTITUTE OF MEDICAL EDUCATlON & RESEARCH, CHANDIGARH No- PGI/MICRO/ICMR-AMR/20l9-20/ 25 Name of Job: Senior Research Fellow No. […]

Related Post

  • BiotechToday
  • World

Cure for Malaria is present inside the human body?

bioxone May 14, 2021May 14, 2021

Anannya Roy, Amity University Kolkata Malaria is a mosquito-borne disease that torments mankind, caused by the parasite plasmodium. Researchers at Walter and Eliza Hall Institute of Medical research have understood how the body’s natural immunity can be manipulated to prevent malaria, bringing us one step closer to new potential therapy. The causative organism of this […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Structural and Functional Inhibition of CHIKV by CHK-124 and CHK-263mAbs

bioxone October 24, 2020October 23, 2020

Souradip Mallick, National Institute of Technology, Rourkela Chikungunya fever is a self-remitting viral illness that is common in tropical countries like Africa and Southeast Asia caused by the Chikungunya virus (CHIKV) (Genus- alphavirus, Family-Togaviridae), single-stranded positive-sense RNA enveloped virus, transmitted to humans by infected Aedes aegypti and Aedes albopictus mosquitoes. International travel is one of the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Microplastics found in human placentas

bioxone February 5, 2021February 5, 2021

Arjama Roy Small pieces of plastic fragments that are less than 5mm in length, commonly referred to as microplastics. Microplastics can move from the environment into human bodies via particular seafood, sea salt, and water. Ingestion of microplastics can expose chemicals that are known to be harmful.  The study published within the Environment International journal; researchers have detected […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy